Akid Ornob

Akid Ornob

Auto-generated profile, based on publicly available information

Akid Ornob

Affiliation Department of Biomedical Engineering, Military Institute of Science and Technology (MIST), Dhaka, Bangladesh

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2017 in Biomedical Microdevices
Verified
Journal Article
Closed access
PDF file
AGA. Ganguli
A. Ganguli
AOA. Ornob
A. Ornob
HYH. Yu
H. Yu
GDGregory L. Damhorst
Gregory L. Damhorst
WCW. Chen
W. Chen
RBR. Bashir
R. Bashir

5 September 2017 in Analytical Chemistry
Verified
Journal Article
Closed access
WCWeili Chen
Weili Chen
HYHojeong Yu
Hojeong Yu
FSFu Sun
Fu Sun
AOAkid Ornob
Akid Ornob
RBRyan Brisbin
Ryan Brisbin
Brian CunninghamBrian Cunningham
Brian Cunningham

15 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
AGA. Ganguli
A. Ganguli
AOA. Ornob
A. Ornob
NSN. Spegazzini
N. Spegazzini
YLY. Liu
Y. Liu
GDGregory L. Damhorst
Gregory L. Damhorst
RBR. Bashir
R. Bashir
Here, we present a technique that performs on-chip picoliter real-time reverse transcriptase loop mediated isothermal amplification (RT-LAMP) reactions on a histological tissue section without any analyte purification while preserving the native spatial location of the nucleic acid molecules. We demonstrate this method by amplifying TOP2A messenger RNA (mRNA) in a prostate cancer xenograft with 100 µm spatial resolution and by visualizing the variation in threshold time of amplification across the tissue. The on-chip reaction was validated by mRNA fluorescence in situ hybridization (mFISH) from cells in the tissue section. The entire process, from tissue loading on microchip to results from RT-LAMP can be carried out in less than 2 h. We anticipate that this technique, with its ease of use, fast turnaround, and quantitative molecular outputs, would become an invaluable tissue analysis tool for researchers and clinicians in the biomedical arena.

5 December 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TNTasnia Nabi
Tasnia Nabi
TRTanver Hasan Riyed
Tanver Hasan Riyed
AOAkid Ornob
Akid Ornob
Rheumatoid arthritis (RA) affects an estimated 0.1% to 2.0% of the world’s population, leading to a substantial impact on global health. The adverse effects and toxicity associated with conventional RA treatment pathways underscore the critical need to seek potential new therapeutic candidates, particularly those of natural sources that can treat the condition with minimal side effects. To address this challenge, this study employed a deep-learning (DL) based approach to conduct a virtual assessment of natural compounds against the Tumor Necrosis Factor-alpha (TNF-α) protein. TNF-α stands out as the primary pro-inflammatory cytokine, crucial in the development of RA. Our predictive model demonstrated appreciable performance, achieving MSE of 0.6, MAPE of 10%, and MAE of 0.5. The model was then deployed to screen a comprehensive set of 2563 natural compounds obtained from the Selleckchem database. Utilizing their predicted bioactivity (pIC50), the top 128 compounds were identified. Among them, 68 compounds were taken for further analysis based on drug-likeness analysis. Subsequently, selected compounds underwent additional evaluation using molecular docking (< − 8.7 kcal/mol) and ADMET resulting in four compounds posing nominal toxicity, which were finally subjected to MD simulation for 200 ns. Later on, the stability of complexes was assessed via analysis encompassing RMSD, RMSF, Rg, H-Bonds, SASA, and Essential Dynamics. Ultimately, based on the total binding free energy estimated using the MM/GBSA method, Imperialine, Veratramine, and Gelsemine are proven to be potential natural inhibitors of TNF-α.

19 July 2016 in Microfluidics and Nanofluidics
Verified
Journal Article
Closed access
PDF file
PDPaula Duarte-Guevara
Paula Duarte-Guevara
CDCarlos Duarte-Guevara
Carlos Duarte-Guevara
AOAkid Ornob
Akid Ornob
RBRashid Bashir
Rashid Bashir

10 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
TNTasnia Nabi
Tasnia Nabi
TRTanver Hasan Riyed
Tanver Hasan Riyed
AOAkid Ornob
Akid Ornob
Rheumatoid arthritis (RA) affects an estimated 0.1% to 2.0% of the world’s population, leading to a substantial impact on global health. The adverse effects and toxicity associated with conventional RA treatment pathways underscore the critical need to seek potential new therapeutic candidates, particularly those of natural sources that can treat the condition with minimal side effects. To address this challenge, this study employed a deep-learning (DL) based approach to conduct a virtual assessment of natural compounds against the Tumor Necrosis Factor-alpha (TNF-α) protein. TNF-α stands out as the primary pro-inflammatory cytokine, crucial in the development of RA. Our predictive model demonstrated appreciable performance, achieving MSE of 0.6, MAPE of 10%, and MAE of 0.5. The model was then deployed to screen a comprehensive set of 2563 natural compounds obtained from the Selleckchem database. Utilizing their predicted bioactivity (pIC 50 ), the top 128 compounds were identified. Among them, 68 compounds were taken for further analysis based on drug-likeness analysis. Subsequently, selected compounds underwent additional evaluation using molecular docking (< − 8.7 kcal/mol) and ADMET resulting in four compounds posing nominal toxicity, which were finally subjected to MD simulation for 200 ns. Later on, the stability of complexes was assessed via analysis encompassing RMSD, RMSF, Rg, H-Bonds, SASA, and Essential Dynamics. Ultimately, based on the total binding free energy estimated using the MM/GBSA method, Imperialine, Veratramine, and Gelsemine are proven to be potential natural inhibitors of TNF-α.